CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,601,199 | +30.1% | 277,515 | -63.8% | 0.01% | +40.0% |
| Q1 2021 | $3,536,000 | -42.0% | 767,041 | -58.0% | 0.01% | +25.0% |
| Q4 2020 | $6,096,000 | +94.5% | 1,825,054 | +77.6% | 0.00% | -20.0% |
| Q3 2020 | $3,134,000 | -58.9% | 1,027,387 | -37.8% | 0.01% | -64.3% |
| Q2 2020 | $7,634,000 | +46.6% | 1,652,211 | +24.4% | 0.01% | +27.3% |
| Q1 2020 | $5,208,000 | +292.8% | 1,328,566 | +275.6% | 0.01% | +450.0% |
| Q4 2019 | $1,326,000 | – | 353,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |